German Chancellor Olaf Scholz visits a new production facility at BioNtech's headquarters, world-famous producer of an mRNA-based anti-Covid vaccine. The new production facility is dedicated to creating plasmids, which are small DNA molecules needed to produce messenger RNA. "We will do everything we can to ensure that the framework conditions, the legal framework conditions, will remain and also be improved," he says. IMAGES AND SOUNDBITES